Björklund Pharma develops science-based nutraceutical and biotech therapies to restore function and improve quality of life. Programs are grounded in mechanistic and clinical research in chronic, debilitating, and life-threatening conditions, with emphasis on brain, immune, and metabolic … Read More
Therapeutic Areas
Björklund Pharma is an early-stage biopharmaceutical company primarily focused on the development and research of thymosin beta-4 (Tβ4), a peptide with significant … Read More
Research and Development
Björklund Pharma focuses on the development of innovative biopharmaceutical products, with a primary focus on thymosin beta-4 (Tβ4). The company prioritizes ensuring … Read More
Collaborations
Björklund Pharma is an early-stage biopharmaceutical company dedicated to addressing critical market needs through innovative research and development. Recognizing the importance of global … Read More